stockrowNatera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.
- Revenue
- +34.1%
- EPS
- +34.4%
- Free cash flow
- −85.8%
- Total debt
- −0.06%
Quarter to September 2026, against a year earlier
Follow NTRA
Alert me
Natera, Inc. (NTRA) Current ratio
Natera, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.8×, down 0.6× from fiscal 2025 (3.4×). Over the past ten years it has ranged from 1.7× (fiscal 2017) to 5.0× (fiscal 2021); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 2.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.4× | (15.16%) |
| FY2024 | 4.0× | (2.37%) |
| FY2023 | 4.1× | 4.95% |
| FY2022 | 3.9× | (21.83%) |
| FY2021 | 5.0× | 15.20% |
| FY2020 | 4.3× | 49.00% |
| FY2019 | 2.9× | 37.83% |
| FY2018 | 2.1× | 23.32% |
| FY2017 | 1.7× | (5.25%) |
| FY2016 | 1.8× | (42.04%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 2.8× | (6.28%) |
| Jun 2026 | 3.0× | 1.35% |
| Mar 2026 | 3.0× | (12.79%) |
| Dec 2025 | 3.4× | 3.61% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| NTRA Natera, Inc. | 2.8× |
| ILMN Illumina, Inc. compare | 2.6× |
| A Agilent Technologies, Inc. compare | 2.1× |
| DGX Quest Diagnostics Incorporated compare | 1.7× |
| LH Labcorp Holdings Inc. compare | 1.4× |
| IDXX IDEXX Laboratories, Inc. compare | 1.2× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| IQV IQVIA Holdings Inc. compare | 0.8× |
| WAT Waters Corporation compare | 0.7× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on NTRA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement